Efficacy of Neurofeedback treatment on Anxiety

Phase 3

Recruiting

Conditions: Generalized Anxiety Disorder.
Generalized anxiety disorder

Registration Number: IRCT20171102037181N1

Lead Sponsor: Zanjan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 30

Inclusion Criteria

Having DSM-5 diagnostic criteria for generalized anxiety disorder diagnosed by a psychiatrist based on diagnostic interview and clinical psychologist; as well as on the basis of the 7-item GAD-7 questionnaire and DSM-5 Clinical Interview for generalized Anxiety Disorder
At least 18 years and maximum 50 years
Study at one of the academic levels
Patient agrees to participate in research and sign a written consent

Exclusion Criteria

Suffering Psychotic disorder And Substance Abuse Based on Diagnostic Interview.
Not receiving psychological treatment at least 6 months before entering the research.
No drug use at least one month before entering the research.
Having complete criteria for personality disorder in axis II based on diagnostic interview.
The apparent risk of suicide is now.
Having more than two absentee sessions.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The severity of the signs and symptoms of generalized anxiety disorder. Timepoint: The effect of neurofeedback treatment in patients with generalized anxiety disorder before, after and three months after treatment. Method of measurement: The score that the subject gained from the GAD-7 questionnaire is the GAD-7. This scale has been developed to diagnose anxiety disorder and to measure the severity of clinical symptoms.

Secondary Outcome Measures